Related Experiment Video
Updated: Jun 4, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Recurrent intracranial hemorrhage with normal routine coagulation tests: delayed diagnosis of Factor XIII deficiency
Ahmed Yasin Yavuz1, Cise Sahin Can1, İrem Özen1
1Department of Neurosurgery, Prof. Dr. Cemil Taşcioğlu City Hospital, Istanbul, Turkey.
Background:
Factor XIII (FXIII) deficiency is a rare autosomal recessive coagulation disorder characterized by impaired fibrin stabilization and delayed bleeding despite normal routine coagulation parameters. Intracranial hemorrhage represents its most severe and life-threatening manifestation, particularly in the infant population.
Case Description:
We report a 5-month-old female infant presenting with a right frontal lesion following minor trauma, initially suggestive of tumor or abscess based on its radiological appearance. The patient underwent craniotomy; however, recurrent postoperative hematomas developed despite consistently normal routine coagulation tests. Further targeted hematological evaluation revealed markedly reduced FXIII activity (15%, reference range 70-140%), confirming the diagnosis of FXIII deficiency. Following initiation of replacement therapy with fresh frozen plasma, no further hemorrhagic episodes occurred.
Conclusion:
Factor XIII deficiency should be considered in infants presenting with recurrent intracranial hemorrhage and normal routine coagulation tests, particularly in the presence of clinical risk factors such as neonatal umbilical bleeding and parental consanguinity. Early targeted laboratory evaluation and prompt initiation of replacement therapy may prevent repeated surgical interventions and improve clinical outcomes.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Hemorrhagic Stroke l: Introduction
Venous Thrombosis III: Interprofessional Care
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
